What does ADMA BIOLOGICS, INC. (ADMA) do?

ADMA BIOLOGICS, INC. (ADMA) is a publicly traded company in the Healthcare sector.

What sector does ADMA operate in?

ADMA BIOLOGICS, INC. operates in the Healthcare, specifically within the Biological Products, (No Diagnostic Substances) industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find ADMA earnings analysis?

AlphaOS publishes an earnings intelligence page for ADMA BIOLOGICS, INC. (ADMA) covering results, guidance context, and AI-assisted analysis. See /stocks/ADMA/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

ADMA

ADMA BIOLOGICS, INC.

Healthcare · Biological Products, (No Diagnostic Substances)

$10.12Sep 28, 2026

AI confidence 70% · refreshes every 15s during session

Investment Snapshot

Weak evidence · 1 source

Why it matters

ADMA BIOLOGICS, INC. shows stable business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +2% YoY in Q2 FY2026.

TrajectoryStable

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +2% YoY in Q2 FY2026

Pipeline evidence · 22d ago

ADMA's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on ADMA.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full ADMA earnings analysis

Reported figures for ADMA BIOLOGICS, INC. — research only, not investment advice.

Revenue YoY: +2.0%
EPS YoY: +14.3%

Latest Intelligence

Updated September 28, 2026

What happened recently for ADMA BIOLOGICS, INC. (ADMA) — events, not interpretation.

Event: Reported Q2 2026 revenue +2% YoY.
Also: Last session September 28, 2026 at $10.12.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

ADMA BIOLOGICS, INC. (ADMA)

Healthcare · Biological Products, (No Diagnostic Substances)

Investment Snapshot above is the primary AlphaOS analysis for ADMA BIOLOGICS, INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Biological Products, (No Diagnostic Substances)
Market cap:: $2.27B
Revenue:: $124.40M

ADMA earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow ADMA BIOLOGICS, INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.